Abstract
Nanoparticles have been included in hundreds of identical types of products, and the novel properties of nanoparticles offers great promise to provide new technological approaches. However nanotechnology is an emerging technology which has prospective health and safety risks throughout its product life cycle. The nanoparticle plays a key role and it can conjugate with different drugs by various methods to deliver drugs to the target site. Clinical applications of different Nano systems in carcinoma therapy such as carbon nanotube, dendrimers, nanocrystal. The expansion in nanotechnology helps in the treatment of Parkinson’s disease and alzheimer’s diseases, Tuberculosis and in Ophthalmology are discussed in this article. Nano pharmaceuticals can be used to perceive diseases at much prior stages. Keywords: Nano particles, Nanotechnology, Clinical application.
Highlights
Nanotechnology involves the scheme of matter on a delivery applications
At the Nano understanding of their interactions with the biological scale, fundamental mechanical, electrical, optical, and environment, target cell population, target cell-surface other properties can significantly differ from their bulk receptors, changes in cell receptors that occur with material counterparts
Micro- and nano-scale organized than larger micro molecules and intelligent systems can maximize the potency of could be used as efficacious transport and delivery therapeutic treatments in numerous ways because they systems
Summary
Nanotechnology involves the scheme of matter on a delivery applications. An potent approach for near atomic scale to producestructures, devices, and achieving systemic drug delivery would be to materials. Nanotechnology is used in hundreds of to target diffrent cellular processes have emerged, products across different industries such as electronics, creating a demand for the development of drug healthcare, chemicals, cosmetics, materials, and delivery systems that can sense and respond directly to energy. Responsive delivery systems that are designed to perform diffrent functions like detection, isolation and/or release of therapeutic agents for the treatment of diseased conditions. To meet these requirements, researchers must be able to interface synthetic and hybrid materials with dynamic biological systems on the micro- and nano-length scale. Liposomes are vesicles consisting of one or more phospholipidic bilayer(s), with an aqueous core (Fig. 1C)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Pharmaceutical Chemistry and Analysis
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
